Luhua Wang

10PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyGeospatial information systems and geospatial data modellingMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 19, 2025
Cortactin Suppresses mTOR-Dependent Senescence in Circulating Tumor Cells.

Jianyang Hu, Binyu Zhang, Junhao Chen

|Dec 07, 2025
PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy.

Yi-Long Wu, Lin Wu, Nan Bi

|Mar 01, 2024
Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol.

Lei Deng, Gulidanna Shayan, Wei Jiang

|Aug 19, 2023
Enhanced prediction of postoperative radiotherapy-induced esophagitis in non-small cell lung cancer: Dosiomic model development in a real-world cohort and validation in the PORT-C randomized controlled trial.

Zeliang Ma, Bin Liang, Ran Wei

|Feb 24, 2023
IDO1 Activity Predicts Lung Toxicity in Patients with Unresectable Stage III NSCLC and Chemoradiotherapy.

Linfang Wu, Yibo Gao, Daquan Wang

|Apr 22, 2022
Treatment outcomes of patients with stage III non-small cell lung cancer and interstitial lung diseases receiving intensity-modulated radiation therapy: A single-center experience of 85 cases.

Linfang Wu, Shijun Zhao, Hui Huang

Pageof 2

Frequent Collaborators

4 joint publications

Zhouguang Hui

3 joint publications

Nan Bi

3 joint publications

Lei Deng

2 joint publications

Linfang Wu